2024-09-012025-08-312025-08-31false11531335SSE Healthcare Limited2026-05-25falseiso4217:GBPxbrli:pure115313352024-08-31115313352025-08-31115313352024-09-012025-08-31115313352023-08-31115313352024-08-31115313352023-09-012024-08-3111531335bus:SmallEntities2024-09-012025-08-3111531335bus:AuditExempt-NoAccountantsReport2024-09-012025-08-3111531335bus:FullAccounts2024-09-012025-08-3111531335bus:PrivateLimitedCompanyLtd2024-09-012025-08-3111531335core:WithinOneYear2025-08-3111531335core:AfterOneYear2025-08-3111531335core:WithinOneYear2024-08-3111531335core:AfterOneYear2024-08-3111531335core:ShareCapital2025-08-3111531335core:SharePremium2025-08-3111531335core:RevaluationReserve2025-08-3111531335core:OtherReservesSubtotal2025-08-3111531335core:RetainedEarningsAccumulatedLosses2025-08-3111531335core:ShareCapital2024-08-3111531335core:SharePremium2024-08-3111531335core:RevaluationReserve2024-08-3111531335core:OtherReservesSubtotal2024-08-3111531335core:RetainedEarningsAccumulatedLosses2024-08-3111531335core:LandBuildings2025-08-3111531335core:PlantMachinery2025-08-3111531335core:Vehicles2025-08-3111531335core:FurnitureFittings2025-08-3111531335core:OfficeEquipment2025-08-3111531335core:NetGoodwill2025-08-3111531335core:IntangibleAssetsOtherThanGoodwill2025-08-3111531335core:ListedExchangeTraded2025-08-3111531335core:UnlistedNon-exchangeTraded2025-08-3111531335core:LandBuildings2024-08-3111531335core:PlantMachinery2024-08-3111531335core:Vehicles2024-08-3111531335core:FurnitureFittings2024-08-3111531335core:OfficeEquipment2024-08-3111531335core:NetGoodwill2024-08-3111531335core:IntangibleAssetsOtherThanGoodwill2024-08-3111531335core:ListedExchangeTraded2024-08-3111531335core:UnlistedNon-exchangeTraded2024-08-3111531335core:LandBuildings2024-09-012025-08-3111531335core:PlantMachinery2024-09-012025-08-3111531335core:Vehicles2024-09-012025-08-3111531335core:FurnitureFittings2024-09-012025-08-3111531335core:OfficeEquipment2024-09-012025-08-3111531335core:NetGoodwill2024-09-012025-08-3111531335core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3111531335core:ListedExchangeTraded2024-09-012025-08-3111531335core:UnlistedNon-exchangeTraded2024-09-012025-08-3111531335core:MoreThanFiveYears2024-09-012025-08-3111531335core:Non-currentFinancialInstruments2025-08-3111531335core:Non-currentFinancialInstruments2024-08-3111531335dpl:CostSales2024-09-012025-08-3111531335dpl:DistributionCosts2024-09-012025-08-3111531335core:LandBuildings2024-09-012025-08-3111531335core:PlantMachinery2024-09-012025-08-3111531335core:Vehicles2024-09-012025-08-3111531335core:FurnitureFittings2024-09-012025-08-3111531335core:OfficeEquipment2024-09-012025-08-3111531335dpl:AdministrativeExpenses2024-09-012025-08-3111531335core:NetGoodwill2024-09-012025-08-3111531335core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3111531335dpl:GroupUndertakings2024-09-012025-08-3111531335dpl:ParticipatingInterests2024-09-012025-08-3111531335dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-012025-08-3111531335core:ListedExchangeTraded2024-09-012025-08-3111531335dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-012025-08-3111531335core:UnlistedNon-exchangeTraded2024-09-012025-08-3111531335dpl:CostSales2023-09-012024-08-3111531335dpl:DistributionCosts2023-09-012024-08-3111531335core:LandBuildings2023-09-012024-08-3111531335core:PlantMachinery2023-09-012024-08-3111531335core:Vehicles2023-09-012024-08-3111531335core:FurnitureFittings2023-09-012024-08-3111531335core:OfficeEquipment2023-09-012024-08-3111531335dpl:AdministrativeExpenses2023-09-012024-08-3111531335core:NetGoodwill2023-09-012024-08-3111531335core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3111531335dpl:GroupUndertakings2023-09-012024-08-3111531335dpl:ParticipatingInterests2023-09-012024-08-3111531335dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3111531335core:ListedExchangeTraded2023-09-012024-08-3111531335dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3111531335core:UnlistedNon-exchangeTraded2023-09-012024-08-3111531335core:NetGoodwill2025-08-3111531335core:IntangibleAssetsOtherThanGoodwill2025-08-3111531335core:LandBuildings2025-08-3111531335core:PlantMachinery2025-08-3111531335core:Vehicles2025-08-3111531335core:FurnitureFittings2025-08-3111531335core:OfficeEquipment2025-08-3111531335core:AfterOneYear2025-08-3111531335core:WithinOneYear2025-08-3111531335core:ListedExchangeTraded2025-08-3111531335core:UnlistedNon-exchangeTraded2025-08-3111531335core:ShareCapital2025-08-3111531335core:SharePremium2025-08-3111531335core:RevaluationReserve2025-08-3111531335core:OtherReservesSubtotal2025-08-3111531335core:RetainedEarningsAccumulatedLosses2025-08-3111531335core:NetGoodwill2024-08-3111531335core:IntangibleAssetsOtherThanGoodwill2024-08-3111531335core:LandBuildings2024-08-3111531335core:PlantMachinery2024-08-3111531335core:Vehicles2024-08-3111531335core:FurnitureFittings2024-08-3111531335core:OfficeEquipment2024-08-3111531335core:AfterOneYear2024-08-3111531335core:WithinOneYear2024-08-3111531335core:ListedExchangeTraded2024-08-3111531335core:UnlistedNon-exchangeTraded2024-08-3111531335core:ShareCapital2024-08-3111531335core:SharePremium2024-08-3111531335core:RevaluationReserve2024-08-3111531335core:OtherReservesSubtotal2024-08-3111531335core:RetainedEarningsAccumulatedLosses2024-08-3111531335core:NetGoodwill2023-08-3111531335core:IntangibleAssetsOtherThanGoodwill2023-08-3111531335core:LandBuildings2023-08-3111531335core:PlantMachinery2023-08-3111531335core:Vehicles2023-08-3111531335core:FurnitureFittings2023-08-3111531335core:OfficeEquipment2023-08-3111531335core:AfterOneYear2023-08-3111531335core:WithinOneYear2023-08-3111531335core:ListedExchangeTraded2023-08-3111531335core:UnlistedNon-exchangeTraded2023-08-3111531335core:ShareCapital2023-08-3111531335core:SharePremium2023-08-3111531335core:RevaluationReserve2023-08-3111531335core:OtherReservesSubtotal2023-08-3111531335core:RetainedEarningsAccumulatedLosses2023-08-3111531335core:AfterOneYear2024-09-012025-08-3111531335core:WithinOneYear2024-09-012025-08-3111531335core:Non-currentFinancialInstrumentscore:CostValuation2024-09-012025-08-3111531335core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-012025-08-3111531335core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-012025-08-3111531335core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-012025-08-3111531335core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-012025-08-3111531335core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-012025-08-3111531335core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3111531335core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3111531335core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3111531335core:Non-currentFinancialInstrumentscore:CostValuation2025-08-3111531335core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-3111531335core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-3111531335core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-3111531335core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-3111531335core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-3111531335core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-3111531335core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-3111531335core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-3111531335core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3111531335core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3111531335core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3111531335core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3111531335core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3111531335core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3111531335core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3111531335core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3111531335core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3111531335bus:Director12024-09-012025-08-3111531335bus:Director22024-09-012025-08-31

SSE Healthcare Limited

Registered Number
11531335
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2025

SSE Healthcare Limited
Company Information
for the year from 1 September 2024 to 31 August 2025

Directors

Seema Dutta
Subhajit Ghosh

Registered Address

19 Courtfield Gardens
Ruislip
HA4 6JL

Registered Number

11531335 (England and Wales)
SSE Healthcare Limited
Statement of Financial Position
31 August 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets314,84016,642
14,84016,642
Current assets
Debtors4524,457223,194
Current asset investments166,133166,133
Cash at bank and on hand181,426350,469
872,016739,796
Creditors amounts falling due within one year5(101,373)(90,132)
Net current assets (liabilities)770,643649,664
Total assets less current liabilities785,483666,306
Net assets785,483666,306
Capital and reserves
Called up share capital100100
Profit and loss account785,383666,206
Shareholders' funds785,483666,306
The financial statements were approved and authorised for issue by the Board of Directors on 25 May 2026, and are signed on its behalf by:
Seema Dutta
Director
Subhajit Ghosh
Director

Registered Company No. 11531335
SSE Healthcare Limited
Notes to the Financial Statements
for the year ended 31 August 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable and net of discounts.Turnover includes revenue earned from the sale of goods and from the rendering of services.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)Straight line (years)
Plant and machinery20-
Office Equipment-3
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 September 2423,0342,59825,632
Additions-2,5202,520
At 31 August 2523,0345,11828,152
Depreciation and impairment
At 01 September 248,6932978,990
Charge for year2,8681,4544,322
At 31 August 2511,5611,75113,312
Net book value
At 31 August 2511,4733,36714,840
At 31 August 2414,3412,30116,642
4.Debtors: amounts due within one year

2025

2024

££
Other debtors522,819213,591
Prepayments and accrued income1,6389,603
Total524,457223,194
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables8642,160
Taxation and social security45,72848,018
Other creditors54,78139,954
Total101,37390,132